Medigen Biotechnology Corporation(TW:3176)
33.25+0.80 (+4.56%)
TW:3176
Medigen Biotechnology Corporation Revenue
33.25
At close:+0.80 (+4.56%)
Medigen Biotechnology Corporation (3176) Revenue
Medigen Biotechnology Corporation Revenue
Medigen Biotechnology Corporation had a revenue of 286.02M in the quarter ending Jun 30, 2026, with 8.85%. This bring the company's revenue in the last twelve months to 1.32B, Decreased 5.36%. In the fiscal year ending Dec 31, 2025, Medigen Biotechnology Corporation had annual revenue of 1.58B with 15.28% growth.
- Revenue (ttm)
- 1.32B
- Revenue Growth
- 1.11%
- P/S Ratio
- 2.92
- Revenue/Employee
- TWD 23,619,448
- Employees
- 67
- Market Cap
- TWD 4.62B
Revenue Chart
Medigen Biotechnology Corporation Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.58B | 209.80M | 15.28% |
| Dec 31, 2024 | 1.37B | 214.98M | 18.57% |
| Dec 31, 2023 | 1.16B | 101.77M | 9.64% |
| Dec 31, 2022 | 1.06B | -2.87B | -73.09% |
| Dec 31, 2021 | 3.92B | 3.31B | 538.80% |
| Dec 31, 2020 | 614.18M | 61.83M | 11.19% |
| Dec 31, 2019 | 552.35M | 145.04M | 35.61% |
| Dec 31, 2018 | 407.31M | -20.17M | -4.72% |
| Dec 31, 2017 | 427.48M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.